Angel Biotechnology will provide biomanufacturing services for EPhaG AS. Angel will support the production of four products over the next three years, for which it will get royalty payments for five years on the sale of the first three products. EPhaG will make a £1m investment in Angel.
Hemscott
Tuesday, 29 April 2008
Angel's Estonian deal
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment